# TB-500 FAQ: Side Effects, Safety, Legal Status, and the Research, Answered

> TB-500 FAQ: side effects, the tumor/angiogenesis signal, FDA and WADA status, dosing in studies, and the fragment-vs-parent caveat — each answer cited to a study or to FDA.

The questions people actually ask about TB-500 — definition, mechanism, safety, dosing, and regulation — each answered straight and cited.

---

The TB-500 record inked panel by panel on blueprint stock — the Ac-LKKTETQ fragment stamped apart from the full-length thymosin beta-4 it is sold as, the empty human-trial panel left visible, and the FDA 503A status struck first; no clinic at the press and nothing here priced or dispensed.